MicroRNA-130b targets PTEN to induce resistance to cisplatin in lung cancer cells by activating Wnt/β-catenin pathway
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA-130b targets PTEN to induce resistance to cisplatin in lung cancer cells by activating Wnt/β-catenin pathway
Authors
Keywords
-
Journal
CELL BIOCHEMISTRY AND FUNCTION
Volume 36, Issue 4, Pages 194-202
Publisher
Wiley
Online
2018-04-14
DOI
10.1002/cbf.3331
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- FEN1 promotes tumor progression and confers cisplatin resistance in non-small-cell lung cancer
- (2017) Lingfeng He et al. Molecular Oncology
- Wnt/β-catenin promotes gastric fundus specification in mice and humans
- (2017) Kyle W. McCracken et al. NATURE
- miR-130b regulates the proliferation, invasion and apoptosis of glioma cells via targeting of CYLD
- (2017) Zhi-Qiang Xiao et al. ONCOLOGY REPORTS
- Treatment advances in small cell lung cancer (SCLC)
- (2017) Saiama N. Waqar et al. PHARMACOLOGY & THERAPEUTICS
- Involvement of the DNA mismatch repair system in cisplatin sensitivity of testicular germ cell tumours
- (2017) Christiane Rudolph et al. CELLULAR ONCOLOGY
- MicroRNAs: pleiotropic players in congenital heart disease and regeneration
- (2017) Sarah C. Hoelscher et al. Journal of Thoracic Disease
- FBW7 mutations mediate resistance of colorectal cancer to targeted therapies by blocking Mcl-1 degradation
- (2016) J Tong et al. ONCOGENE
- BRAFV600E-dependent Mcl-1 stabilization leads to everolimus resistance in colon cancer cells
- (2016) Kan He et al. Oncotarget
- Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing
- (2015) Yao-Yin Chang et al. Molecular Cancer
- MiR-130b inhibits proliferation and induces apoptosis of gastric cancer cells via CYLD
- (2015) Baoyou Sun et al. TUMOR BIOLOGY
- Therapeutic Targeting of Cancers with Loss of PTEN Function
- (2014) Lloye Dillon et al. CURRENT DRUG TARGETS
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- MicroRNA silencing for cancer therapy targeted to the tumour microenvironment
- (2014) Christopher J. Cheng et al. NATURE
- MicroRNAs in cancer: biomarkers, functions and therapy
- (2014) Josie Hayes et al. TRENDS IN MOLECULAR MEDICINE
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature
- (2013) Martin P. Barr et al. PLoS One
- The functions and regulation of the PTEN tumour suppressor
- (2012) Min Sup Song et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Icaritin Causes Sustained ERK1/2 Activation and Induces Apoptosis in Human Endometrial Cancer Cells
- (2011) Jing-Shan Tong et al. PLoS One
- MicroRNAs: Synthesis, mechanism, function, and recent clinical trials
- (2010) Fazli Wahid et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
- (2009) Bryan T. MacDonald et al. DEVELOPMENTAL CELL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started